diagnostic relevance of agnor in ovarian serous borderline tumors
نویسندگان
چکیده
nucleolar organizer regions are loops a/nuclear dna related to ribosomal dna, and their number in cells is believed to indicate cellular proliferative activity. using_a silver staining methodto visualize thesestructures inparaffin embeddedtissue sections, an attempt was made to determine ifthese agnor counts could be used as a diagnostic toolfor serous borderline tumors of the ovary. ten cases in each group a/benign, borderlineand malignantserous ovarian tumorswereselectedand themean numberofagnorwas determined in all cases. a progressive increase in mean agnorvalues was naedfrom the benign l oup towards the borderlinegroup and further to the carcinomagroupi the differences between the means in. each gr~uwere statistically significant however, there was a high ee of overlap between the values ofthe borderline and . ant groups. theseresults indicatethat agnorcountsmaynot be very useful as a diagnostic tool in an individual case.
منابع مشابه
MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation
BACKGROUND Serous borderline tumor (SBT) of the micropapillary type (SBT-MP) became one of the major pathological SBT diagnoses in addition to typical SBT, and was also defined as "non-invasive" low-gradeserous carcinoma according to the World Health Organization (WHO) classification in 2014. In this study, we investigated the MRI appearance of SBT-MP compared to that of typical SBT in order to...
متن کاملBorderline Ovarian Serous Adenofibromatous tumor with Prominent Micropapillary Pattern
Ovarian borderline serous tumors are uncommon. Combination of borderline serous adenofibromatous tumor and prominent micro papillary architecture is not previously reported. We report a case of borderline papillary serous adenofibromatous tumor (also called serous adenocarcinofibroma) with extensive micropapillary pattern in a 27 year-old married woman. She was infertile and presented with diff...
متن کاملControversies in borderline ovarian tumors
Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal washing cytology, hysterectomy, bilateral salpingo-oophorectomy, omentectomy, complete peritoneal resection of macroscopic lesions; in case of mucinous BOTs, appendectomy should be perfo...
متن کاملRecurrence of borderline ovarian tumors.
AIM To increase the efficiency of diagnosis and treatment of patients with recurrences of borderline ovarian tumors (BOT). MATERIALS AND METHODS 106 patients with BOT of stage I have been treated and clinically observed: the I group (82 patients, mean age -- 38.9 ± 5.5 years), who were treated with standard surgical operation (panhysterectomy); the II group (24 patients, mean age -- 30.3 ± 5....
متن کاملThe study of p53 and p16 immunoexpression in serous borderline and malignant ovarian tumors.
The study assessed p53 and p16 immunoexpression in 20 cases of ovarian serous carcinomas and four cases of serous borderline tumors, the results being statistically analyzed in relation to clinicopathological data of the cases. The p53 immunoreaction was observed in 85% of cases, the medium percentage of positivity being 15% for borderline tumors, 45% for low-grade carcinomas and 60% for high-g...
متن کاملPrognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.
The purpose of this study was to investigate the frequency of p53 overexpression in the primary ovarian tumors of patients with stages II and III serous borderline tumors (SBTs) and to determine the relationship between p53 overexpression and risk of progression/recurrence and survival. Of 112 patients with stages II-IV SBTs, paraffin-embedded tissue from the primary ovarian tumor was available...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
acta medica iranicaجلد ۳۳، شماره ۱-۲، صفحات ۱۸-۲۱
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023